“Israel spends the most of any country on R&D, and is where entrepreneurial culture is the strongest, the acceptance for entrepreneurial failure the highest, where companies embrace change the most, and where innovative companies grow the fastest,” according to the Global Competitiveness Report 2019 by the World Economic Forum. In such a climate, the significant role of the Israel Innovation Authority (IIA) in the local innovation ecosystem is vital.
Previously known as the Office of the Chief Scientist, and otherwise known as the National Authority for Technological Innovation, the IIA provides start-ups with access to incubators, innovation labs and a host of other programs. Clients benefit from working with experts with an in-depth knowledge of these programs, a profound knowledge of the rules governing them, the restrictions they entail on exporting knowhow developed with IIA funding and how the organization works. Amit, Pollak, Matalon & Co. (“APM & Co.”) is your expert.
Thriving under the leadership of partner Stephen Barak Rozen, APM & Co.’s Israel Innovation Authority practice specializes in advising clients on all matters relating to the IIA’s benefit tracks, rules and regulations. As part of this, we act for many entities that operate under the auspices of the IIA, or that vie for franchises to operate under the IIA’s auspices.
We advise early stage start-ups, late stage start-ups and global multinationals on compliance issues and reporting requirements, as stipulated by the IIA, as they relate to their transactions – commercial, licensing, M&A and other.
We also give lectures on matters relating to the IIA, and previous audiences have included the Israeli Ministry of Agriculture, the Hebrew University of Jerusalem and the Open University.
Given our immersion in the field of technology, venture capital and the IIA, clients are reassured that they have come to the right place to navigate this complex field.
